Table 1 Demographic and clinical characteristics of study populations.
ALS | controls | |
|---|---|---|
Total number (n) | 73 | 48 |
Sex m/f (%) | 42.50/57.50 | 52.10/47.90 |
Age in years ± SD | 66.65 ± 9.41 | 63.40 ± 12.10 |
Onset b/s (n) | 21/52 | NA |
Disease duration in years (Range) | 2.48 (0.12–12.02) | NA |
Body height in m (Range) | 1.69 (1.52–1.88) | NA |
Weight in kg (Range) | 72.4 (39.0–132.0) | NA |
BMI (Range) | 25.4 (16.88–40.12) | NA |
FVC in ml (Range) | 1918 (100–4850) | NA |
ppFVC in % (Range) | 61.4 (2.53–131.32) | NA |
ALSFRS-R (Range) | 33 (0–47.0) | NA |
ALSFRS-R slope (Range) | 0.80 (0.01–3.34) | NA |
Supportive Care (IV, NIV, PEG) (n) | 17 | 0 |
IV (n) | 6 | 0 |
NIV (n) | 10 | 0 |
PEG (n) | 6 | 0 |
